Cardio-Metabolic Risk Profile of Women With Endometriosis: A Population-Based Study

IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM Endocrinology, Diabetes and Metabolism Pub Date : 2024-10-13 DOI:10.1002/edm2.70008
Marzieh Saei Ghare Naz, Mahsa Noroozzadeh, Shahla Noori Ardebili, Maryam Mousavi, Fereidoun Azizi, Fahimeh Ramezani Tehrani
{"title":"Cardio-Metabolic Risk Profile of Women With Endometriosis: A Population-Based Study","authors":"Marzieh Saei Ghare Naz,&nbsp;Mahsa Noroozzadeh,&nbsp;Shahla Noori Ardebili,&nbsp;Maryam Mousavi,&nbsp;Fereidoun Azizi,&nbsp;Fahimeh Ramezani Tehrani","doi":"10.1002/edm2.70008","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>Endometriosis (EM) and metabolic disorders are frequent health problems among reproductive-aged women worldwide. Cardio-metabolic risk profile of women with EM is not well understood. We aimed to investigate the cardio-metabolic risk profile of Iranian reproductive-aged women with EM.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This study included 976 female participants aged 20–45 years of Tehran Lipid and Glucose Study. Endometriosis was diagnosed based on the participants' self-reported previous diagnosis of EM, which was confirmed by reviewing the relevant medical documentation. All biochemical measures (low-density lipoprotein cholesterol [LDL], high-density lipoprotein cholesterol [HDL], triglycerides [TG], and fasting blood glucose concentrations [FBG]) and measurement of systolic blood pressure (SBP) and diastolic blood pressure (DBP) and anthropometric parameters were performed according to the standard protocol of TLGS. Logistic regression analysis was performed to estimate the odds ratio of cardio-metabolic disease.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the 976 study participants, 161 individuals (16.5%) had a confirmed diagnosis of endometriosis. There were no significant differences in the median of metabolic parameters among women with and without endometriosis (<i>p</i> &gt; 0.05). The prevalence of metabolic syndrome was significantly higher in women with EM group compared to the non-EM group (21.9% vs. 14.9%). The presence of endometriosis was associated with an increased odds of metabolic syndrome (adjusted odds ratio 1.99 [95% CI 1.20–3.30]; <i>p</i> = 0.007). And endometriosis significantly increased odds of low HDL by 2.07 (1.02–4.20); after adjustment, it still remained significant (<i>p</i> = 0.03). Endometriosis also increased odds of high waist circumstance significantly (1.58 [1.06–2.37]; <i>p</i> = 0.02).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Women with endometriosis may be at an increased risk of developing metabolic syndrome, high waist circumstance and low HDL compared to their counterparts without the condition. Given the potential cardio-metabolic implications, healthcare providers should consider assessing the metabolic profile of women diagnosed with endometriosis.</p>\n </section>\n </div>","PeriodicalId":36522,"journal":{"name":"Endocrinology, Diabetes and Metabolism","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/edm2.70008","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinology, Diabetes and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/edm2.70008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

Endometriosis (EM) and metabolic disorders are frequent health problems among reproductive-aged women worldwide. Cardio-metabolic risk profile of women with EM is not well understood. We aimed to investigate the cardio-metabolic risk profile of Iranian reproductive-aged women with EM.

Methods

This study included 976 female participants aged 20–45 years of Tehran Lipid and Glucose Study. Endometriosis was diagnosed based on the participants' self-reported previous diagnosis of EM, which was confirmed by reviewing the relevant medical documentation. All biochemical measures (low-density lipoprotein cholesterol [LDL], high-density lipoprotein cholesterol [HDL], triglycerides [TG], and fasting blood glucose concentrations [FBG]) and measurement of systolic blood pressure (SBP) and diastolic blood pressure (DBP) and anthropometric parameters were performed according to the standard protocol of TLGS. Logistic regression analysis was performed to estimate the odds ratio of cardio-metabolic disease.

Results

Of the 976 study participants, 161 individuals (16.5%) had a confirmed diagnosis of endometriosis. There were no significant differences in the median of metabolic parameters among women with and without endometriosis (p > 0.05). The prevalence of metabolic syndrome was significantly higher in women with EM group compared to the non-EM group (21.9% vs. 14.9%). The presence of endometriosis was associated with an increased odds of metabolic syndrome (adjusted odds ratio 1.99 [95% CI 1.20–3.30]; p = 0.007). And endometriosis significantly increased odds of low HDL by 2.07 (1.02–4.20); after adjustment, it still remained significant (p = 0.03). Endometriosis also increased odds of high waist circumstance significantly (1.58 [1.06–2.37]; p = 0.02).

Conclusions

Women with endometriosis may be at an increased risk of developing metabolic syndrome, high waist circumstance and low HDL compared to their counterparts without the condition. Given the potential cardio-metabolic implications, healthcare providers should consider assessing the metabolic profile of women diagnosed with endometriosis.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
子宫内膜异位症妇女的心血管代谢风险概况:一项基于人群的研究
目的 子宫内膜异位症(EM)和代谢紊乱是全球育龄妇女经常遇到的健康问题。人们对患有子宫内膜异位症的妇女的心血管代谢风险还不甚了解。我们旨在调查伊朗育龄妇女的心血管代谢风险情况。 方法 这项研究包括德黑兰血脂和血糖研究中 976 名 20-45 岁的女性参与者。子宫内膜异位症的诊断依据是参与者自我报告的先前 EM 诊断,并通过查阅相关医疗文件予以确认。所有生化指标(低密度脂蛋白胆固醇[LDL]、高密度脂蛋白胆固醇[HDL]、甘油三酯[TG]和空腹血糖浓度[FBG])、收缩压(SBP)和舒张压(DBP)以及人体测量参数的测量均按照TLGS的标准方案进行。采用逻辑回归分析估算心血管代谢疾病的几率。 结果 在 976 名研究参与者中,161 人(16.5%)确诊患有子宫内膜异位症。患有和未患有子宫内膜异位症的妇女的代谢参数中位数无明显差异(P > 0.05)。与未患子宫内膜异位症的妇女相比,患子宫内膜异位症的妇女患代谢综合征的比例明显更高(21.9% 对 14.9%)。子宫内膜异位症的存在与代谢综合征几率的增加有关(调整后的几率比 1.99 [95% CI 1.20-3.30];P = 0.007)。子宫内膜异位症会使低高密度脂蛋白的几率明显增加 2.07(1.02-4.20);经过调整后,该几率仍然显著(p = 0.03)。子宫内膜异位症也明显增加了高腰围的几率(1.58 [1.06-2.37]; p = 0.02)。 结论 与无子宫内膜异位症的妇女相比,患有子宫内膜异位症的妇女患代谢综合征、高腰围和低高密度脂蛋白的风险可能会增加。鉴于子宫内膜异位症对心脏代谢的潜在影响,医疗服务提供者应考虑对确诊患有子宫内膜异位症的妇女进行代谢状况评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Endocrinology, Diabetes and Metabolism
Endocrinology, Diabetes and Metabolism Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.00
自引率
0.00%
发文量
66
审稿时长
6 weeks
期刊最新文献
Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes—Findings From a Cross-Sectional Study The Causal Role of Thyroid Hormones in Bipolar Disorders: A Two-Sample Mendelian Randomization Study Trends and Disparities in Coronary Artery Disease and Obesity-Related Mortality in the United States From 1999–2022 Comparative Efficacy of Magnesium and Potassium Towards Cholesterol and Quality of Life in Patients With Type 2 Diabetes Mellitus: A Randomised Single-Blinded Controlled Clinical Trial Cardio-Metabolic Risk Profile of Women With Endometriosis: A Population-Based Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1